BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8008198)

  • 21. Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats.
    Stauch Slusher B; Rissolo KC; Anzilotti KF; Jackson PF
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):145-9. PubMed ID: 8526999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
    Bordet R; Ridray S; Schwartz JC; Sokoloff P
    Eur J Neurosci; 2000 Jun; 12(6):2117-23. PubMed ID: 10886351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
    Trugman JM; James CL; Wooten GF
    Brain; 1991 Jun; 114 ( Pt 3)():1429-40. PubMed ID: 1829645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.
    Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N
    Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC; Chase TN; Engber TM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment.
    He L; Di Monte DA; Langston JW; Quik M
    Neuroscience; 2000; 99(4):697-704. PubMed ID: 10974432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus.
    Honey CR; Shen H
    Neurosci Lett; 1998 Jun; 249(2-3):151-4. PubMed ID: 9682839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative autoradiography of 5-[3H]6-cyano-7-nitro-quinoxaline-2,3-dione and (+)-3-[3H]dizocilpine maleate binding in rat vestibular nuclear complex after unilateral deafferentation, with comparison to cochlear nucleus.
    Li H; Godfrey DA; Rubin AM
    Neuroscience; 1997 Mar; 77(2):473-84. PubMed ID: 9472405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion.
    Porter RH; Greene JG; Higgins DS; Greenamyre JT
    J Neurosci; 1994 Nov; 14(11 Pt 2):7192-9. PubMed ID: 7965108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.
    Armentero MT; Fancellu R; Nappi G; Bramanti P; Blandini F
    Neurobiol Dis; 2006 Apr; 22(1):1-9. PubMed ID: 16289868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.
    Suzdak PD; Sheardown MJ
    J Neurochem; 1993 Oct; 61(4):1577-80. PubMed ID: 8397300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice.
    Laudrup P; Klitgaard H
    Eur J Pharmacol; 1993 Nov; 250(1):15-22. PubMed ID: 7509749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    PĂ©rier C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
    Maranis S; Stamatis D; Tsironis C; Konitsiotis S
    Eur J Pharmacol; 2012 May; 683(1-3):71-7. PubMed ID: 22410193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-talk between excitatory and inhibitory amino acids in the regulation of growth hormone secretion in neonatal rats.
    Pinilla L; Gonzalez LC; Tena-Sempere M; Aguilar E
    Neuroendocrinology; 2001 Jan; 73(1):62-7. PubMed ID: 11174018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.